Disparate results from two gene therapy developers are worth a mention in this week’s biotech recap. Avalanche Biotechnologies Inc (NASDAQ:AAVL) blew up spectacularly …
Recently, various executives have taken part in insider selling activity for the stocks of Avalanche Biotechnologies Inc (NASDAQ:AAVL), Novavax, Inc. (NASDAQ:NVAX), Yelp Inc …
Piper Jaffray analyst Joshua Schimmer weighed in today with his views on Avalanche Biotechnologies Inc (NASDAQ:AAVL) after the company reported its highly anticipated results of …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
The latest in the onslaught of biotech initial public offerings, Spark Therapeutics (ONCE) priced at $23 on Thursday evening. Twelve hours later, the stock opened at …
